X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5751) 5751
Publication (602) 602
Book Review (137) 137
Book Chapter (73) 73
Newsletter (51) 51
Book / eBook (12) 12
Conference Proceeding (12) 12
Magazine Article (12) 12
Newspaper Article (7) 7
Dissertation (6) 6
Reference (2) 2
Trade Publication Article (2) 2
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (3174) 3174
index medicus (2780) 2780
humans (2616) 2616
male (2136) 2136
rats (1675) 1675
angiotensin (1516) 1516
hypertension (1179) 1179
angiotensin-ii (1175) 1175
pharmacology & pharmacy (1116) 1116
female (1047) 1047
oxidative stress (932) 932
mice (804) 804
angiotensin ii (727) 727
renin-angiotensin system (680) 680
rats, sprague-dawley (604) 604
blood pressure - drug effects (553) 553
angiotensin-converting enzyme inhibitors - therapeutic use (535) 535
expression (499) 499
urology & nephrology (496) 496
disease models, animal (489) 489
blood-pressure (483) 483
cardiac & cardiovascular systems (479) 479
angiotensin-converting enzyme (478) 478
rats, wistar (471) 471
analysis (446) 446
biochemistry & molecular biology (441) 441
inflammation (437) 437
physiology (437) 437
peripheral vascular disease (432) 432
blood pressure (430) 430
enzymes (424) 424
middle aged (424) 424
research (401) 401
renin-angiotensin system - drug effects (395) 395
toxicology (395) 395
hypertension - drug therapy (387) 387
risk factors (385) 385
cells, cultured (384) 384
health aspects (382) 382
aged (380) 380
rodents (379) 379
physiological aspects (375) 375
fibrosis (360) 360
angiotensin ii - pharmacology (356) 356
cell biology (354) 354
apoptosis (352) 352
proteins (352) 352
article (350) 350
adult (342) 342
angiotensin-converting enzyme inhibitors - pharmacology (341) 341
heart failure (341) 341
kidney - drug effects (334) 334
angiotensin ii - toxicity (327) 327
mice, inbred c57bl (323) 323
dose-response relationship, drug (315) 315
medicine & public health (312) 312
activation (300) 300
medicine, research & experimental (299) 299
care and treatment (295) 295
diabetes (289) 289
nitric oxide (287) 287
hypertension - physiopathology (282) 282
heart (275) 275
hypertension - chemically induced (275) 275
heart-failure (274) 274
medicine (270) 270
inhibition (269) 269
nitric-oxide (260) 260
oxidative stress - drug effects (253) 253
mortality (252) 252
time factors (251) 251
gene expression (250) 250
oncology (246) 246
angiotensin ii - metabolism (242) 242
kidney - pathology (241) 241
treatment outcome (239) 239
smooth-muscle-cells (238) 238
renin (237) 237
cancer (236) 236
endocrinology & metabolism (236) 236
reactive oxygen species - metabolism (234) 234
signal transduction (233) 233
angiotensin ii type 1 receptor blockers - pharmacology (232) 232
antihypertensive agents - therapeutic use (232) 232
neurosciences (232) 232
drug therapy (230) 230
disease (224) 224
kidney (223) 223
toxicity (221) 221
research article (219) 219
pregnancy (213) 213
cells (212) 212
kidney - metabolism (212) 212
gene-expression (211) 211
myocardial-infarction (211) 211
internal medicine (210) 210
cardiology (209) 209
ace inhibitors (208) 208
heart failure - drug therapy (207) 207
nitric-oxide synthase (207) 207
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5830) 5830
Japanese (14) 14
Chinese (13) 13
French (11) 11
Russian (6) 6
Spanish (4) 4
German (3) 3
Korean (1) 1
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal Article
Circulation Research: Journal of the American Heart Association, ISSN 0009-7330, 10/2003, Volume 93, Issue 8, pp. 767 - 775
ABSTRACT—Intracellular signaling pathway mediated by small GTPase Rho and its effector Rho-kinase plays an important role in regulation of vascular smooth... 
Rho-kinase | Superoxide anion | Angiotensin II | Cardiovascular hypertrophy | Arteriosclerosis | NADPH OXIDASE | CARDIAC & CARDIOVASCULAR SYSTEMS | MESSENGER-RNA EXPRESSION | TYROSINE KINASES | arteriosclerosis | CHEMOATTRACTANT PROTEIN-1 EXPRESSION | angiotensin II | cardiovascular hypertrophy | GENE-EXPRESSION | PERIPHERAL VASCULAR DISEASE | SMOOTH-MUSCLE-CELLS | HEMATOLOGY | superoxide anion | CORONARY-ARTERY SPASM | HYPERTENSIVE-RATS | MYOSIN PHOSPHATASE | NEOINTIMAL FORMATION | NADPH Oxidases - metabolism | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives | Rats, Inbred WKY | Cardiomegaly - pathology | Endothelium, Vascular - drug effects | Male | Vasoconstrictor Agents - toxicity | Endothelium, Vascular - enzymology | Hypertension - chemically induced | rho-Associated Kinases | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Superoxides - metabolism | Angiotensin II - toxicity | Organ Culture Techniques | Macrophages - physiology | Coronary Vessels - pathology | Protein-Serine-Threonine Kinases - physiology | Endothelium, Vascular - physiopathology | Enzyme Inhibitors - pharmacology | Intracellular Signaling Peptides and Proteins | Rats | Cardiomegaly - enzymology | Aorta, Thoracic - cytology | Cell Movement - drug effects | Animals | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology | Cardiomegaly - chemically induced | Macrophages - drug effects | Vasodilation - drug effects
Journal Article
Journal Article